Daniel J. Farrugia

Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers

Wataru Sakai, Elizabeth M. Swisher, Beth Y. Karlan et al. · Nature · 2008 · 1.1K citations · Full text

Cisplatin Resistance, Somatic Variant, Tumor Heterogeneity +10

Mcl-1 Mediates Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Resistance in Human Cholangiocarcinoma Cells

Makiko Taniai, Annette Grambihler, Hajime Higuchi et al. · Cancer Research · 2004 · 215 citations · Full text

Functional Evaluation and Cancer Risk Assessment of BRCA2 Unclassified Variants

Kangjian Wu, Shannon R. Hinson, Akihiro Ohashi et al. · Cancer Research · 2005 · 114 citations · Full text

Germ Line Brca2, Genome Instability, Oncology +15

Functional Assays for Classification of<i>BRCA2</i>Variants of Uncertain Significance

Daniel J. Farrugia, Mukesh K. Agarwal, V. Shane Pankratz et al. · Cancer Research · 2008 · 108 citations · Full text

Low Estrogen Receptor (ER)–Positive Breast Cancer and Neoadjuvant Systemic Chemotherapy

Alessandra Landmann, Daniel J. Farrugia, Li Zhu et al. · American Journal of Clinical Pathology · 2018 · 76 citations · Full text